TRANSITIONAL CELL CARCINOMA
Clinical trials for TRANSITIONAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSITIONAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for TRANSITIONAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Dietary change explored as cancer support strategy
Knowledge-focused Recruiting nowThis early-stage study tests whether people with advanced solid tumors can safely follow a diet low in methionine, an amino acid found in many proteins. Researchers will measure how well participants stick to the diet, check for side effects, and track changes in blood methionine…
Matched conditions: TRANSITIONAL CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Protein level may predict immunotherapy success in four cancers
Knowledge-focused Recruiting nowThis study is observing 300 adults with kidney, bladder, lung, or liver cancer who are starting immunotherapy (PD-1/PDL-1 inhibitors). Researchers will measure a protein called Galectin-3 in the blood before each treatment to see if its level is linked to how well the therapy wor…
Matched conditions: TRANSITIONAL CELL CARCINOMA
Sponsor: Daniel Keizman • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC